Merit Medical Rings Nasdaq Opening Bell to Celebrate 35-Year Partnership
Rhea-AI Summary
Merit Medical Systems (NASDAQ: MMSI) is set to celebrate its 35-year partnership with Nasdaq by ringing the opening bell at the Nasdaq MarketSite in Times Square on March 19, 2025. Chairman and CEO Fred Lampropoulos will lead the ceremony starting at 9:15 A.M. (EDT), with the bell ringing at 9:30 A.M.
Founded in 1987, Merit Medical has established itself as a global leader in healthcare technology, specializing in proprietary medical devices for interventional, diagnostic, and therapeutic procedures. The company focuses on cardiology, radiology, oncology, critical care, and endoscopy sectors.
With a workforce of approximately 7,400 people worldwide, Merit Medical maintains a robust presence through its domestic and international sales force and clinical support team of over 800 individuals.
Positive
- None.
Negative
- None.
News Market Reaction
On the day this news was published, MMSI declined 0.73%, reflecting a mild negative market reaction.
Data tracked by StockTitan Argus on the day of publication.
SOUTH JORDAN, Utah, March 18, 2025 (GLOBE NEWSWIRE) -- Merit Medical Systems, Inc. (NASDAQ: MMSI), a global leader of healthcare technology, announced that Chairman and Chief Executive Officer, Fred Lampropoulos, will visit the Nasdaq MarketSite in Times Square to ring the opening bell on Wednesday, March 19, 2025. The ceremony begins at 9:15 A.M. (EDT) and the bell ringing takes place at 9:30 A.M.
"Merit’s listing on Nasdaq for 35 years marks a significant milestone in our company’s history,” said Lampropoulos. “Nasdaq has been an exceptional partner, providing Merit with strong execution and visibility within the investor community. We extend our sincere appreciation for Nasdaq’s on-going support. We are honored to be a part of the great businesses listed on Nasdaq."
View the entire bell ringing ceremony here.
ABOUT MERIT
Founded in 1987, Merit Medical Systems, Inc. is engaged in the development, manufacture, and distribution of proprietary medical devices used in interventional, diagnostic, and therapeutic procedures, particularly in cardiology, radiology, oncology, critical care, and endoscopy. Merit serves customers worldwide with a domestic and international sales force and clinical support team totaling more than 800 individuals. Merit employs approximately 7,400 people worldwide.
TRADEMARKS
Unless noted otherwise, trademarks and registered trademarks used in this release are the property of Merit Medical Systems, Inc., its subsidiaries, or its licensors.
CONTACTS
PR/Media Inquiries
Sarah Comstock
Merit Medical
+1-801-432-2864 | sarah.comstock@merit.com
INVESTOR INQUIRIES
Mike Piccinino, CFA, IRC
Westwicke - ICR
+1-443-213-0509 | mike.piccinino@westwicke.com